• Glucose-6-Phosphate Dehydrogenase (G6PD), Screen
  • Iron, Serum
  • Platelet Function Analysis
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • Heparin Induced Antibody
  • HER2/neu (ERBB2) Gene Amplification, FISH, Urothelial Carcinoma
  • Human Growth Hormone (Somatotropin)
  • Vitamin D, 25-Hydroxy, fractions (D2 and D3)
  • Ehrlichia chaffeensis and Anaplasma Species by Real-Time PCR
  • Legionella pneumophila Antibody, IgG by IFA
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Bladder Tumor Antigen (BTA)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Bladder Tumor Antigen (BTA)
Medical Test

Turnaround Time
Access to Bladder Tumor Antigen (BTA) is restricted.